Page 24 - JCTR-9-4
P. 24
240 Marchand et al. | Journal of Clinical and Translational Research 2023; 9(4): 236-245
Fat emulsion infusion significantly improved clinical pregnancy rate, implantation rate, and the live birth rates in IVF/ICSI in women with RIF. Fat emulsion therapy did not significantly improve live birth rates in women with unexplained RIF undergoing IVF treatment.
NA NA NA
N
NA NA NA NA
NA NA NA NA
NA NA NA NA
1.94±0.31 1.93±0.33 NA NA
5.1±1.4 4.9±1.7 NA NA
10,000 IU 10,000 IU
HMG HMG NA: Not available, IVF/ICSI: In vitro fertilization/intracytoplasmic sperm injection, RIF: Recurrent implantation failure, HMG: Human menopausal gonadotropin, HCG: Human chorionic gonadotropin, GnRH: Gonadotropin-
Long agonist Long agonist
Triptorelin acetate Triptorelin acetate releasing hormone, Gn: Gonadotropin, rFSH: Recombinant Follicle-stimulating hormone, rHCG: Recombinant human chorionic gonadotropin, IU: International unit, SD: Standard deviation
24.7±4.7 24.1±4.3 NA NA
35.1±3.5 35±3.6 35±3.4 35.4±3.2
101 102 48 49
Egypt United Kingdom (UK)
Table 1. (Continued) Fat emulsion El-Khayat group and El (Two doses of Sadek 2 mL 20% fat (2015)[26] emulsion in 250 mL normal saline; infusion between days 4–9 of ICSI and 1 dose within first week of positive pregnancy test) Control group (normal saline) Gamaleldin Fat emulsion group (Two (2018)[28] doses of 2 mL 20% fat emulsion in 250 mL normal saline) Control group (normal saline)
et al.
DOI: http://dx.doi.org/10.18053/jctres.09.202304.23-00060
